Answer
It is licensed for secondary hyperparathyroidism in children aged 3 years and older receiving maintenance dialysis when standard care has not adequately controlled the condition. Specialist monitoring is essential.
Sources for this answer
- Mimpara granules in capsulesemc · SmPC Current selected SmPC · Version 4